Suyzeko/Ssch 2023 Private Label Red Light Therapy Bed for Health Care

Name: Suyzeko/Ssch 2023 Private Label Red Light Therapy Bed for Health Care
Brand: Shenzhen Guangyang Zhongkang Technology Co., Ltd.
SKU: 2079206475

Guangdong, ChinaShenzhen Guangyang Zhongkang Technology Co., Ltd.

US$25,600.00

1 Piece

US$21,600.00

2-9 Pieces

US$19,600.00

10+ Pieces

Sample price:US$25600.00/piece.Request sample

Product profile

Customization

Available

Type

PDT Machine

Theory

E-Light

Model NO.

GY-W4L

Application

Salon, Home

Portable

Non Portable

Warranty

2 Years

After-Sales Service Provided

Free Spare Parts

Product Name

LED PDT Skin Rejuvenation Bed

Wavelength

635nm 660nm 810nm 850nm 940nmnm

LED Using Time

100000h

Frequency

0-5000Hz

LED Quantity

3600PCS/26400PCS

Time

0-30mins

Power

3500W

Irradiance

120 MW/Cm2

Lamp Power

3W/200MW

Feature

Skin Tightening

Light Source

80 LED Strips

Target Area

Body, Face, Feet, Head

Transport Package

Wood Crate

Specification

201*110*97cm

Trademark

Suyzeko

Origin

China

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceR&D CapabilitiesProduct Certification

Shenzhen Guangyang Zhongkang Technology Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableAverage Response Time: ≤9.05h

AI-Powered supplier vetting

SummaryThe supplier demonstrates broad customization and R&D capabilities, including full customization, ODM services, recent product development, and three R&D engineers. Quality and service processes are documented, with ISO9001:2015, CE, and FCC certifications. It has 11 years of export experience, self-operated import/export rights, and exports representing 90% of total sales. Production-related evidence is limited, although the supplier reports OEM service for well-known brands and maintains quality inspection procedures. After-sales support is supported by technical assistance and documented complaint, corrective-action, and preventive-action procedures, but overseas service infrastructure is absent. Financial credibility cannot be assessed because the provided records identify years rather than financial results. Customer evidence includes OEM service for well-known brands and a 50%–80% repeat-buyer preference, but no Fortune 500 cooperation.

CertificationsThe supplier holds an ISO9001:2015 management-system certificate and reports CE and FCC product compliance certifications. These certifications provide explicit evidence of quality-system and product-compliance credentials.

After-Sales capabilityR&D engineers are responsible for technical support during production and after-sales service. The supplier also has documented and followed procedures for customer complaints and corrective and preventive actions, although no overseas warehouse, showroom, agent, or branch is available.

R&D capabilityThe supplier reports new products during the past year, ODM service, three R&D engineers, and responsibilities covering customer requirements, technical support, and new product development. However, it has no available SDK, so its innovation capability is supported for product development but not SDK-based integration.

Production capacityThe supplier reports OEM service for well-known brands, standardized finished-product inspection instructions, written warehouse quality-control procedures with records, two quality-control staff, and one test-equipment unit. These indicate operational and quality-control capability, though detailed production capacity and equipment information is not provided.

Customization capabilityThe supplier explicitly offers customization from samples and designs, full, minor, and flexible customization, together with ODM services. This is strong direct evidence of broad customization capability.

Client casesThe supplier reports OEM service for well-known brands, participation in the CMEF trade show, and a 50%–80% repeat-buyer preference. It reports no Fortune 500 cooperation, so the available customer evidence is positive but does not establish Fortune 500 experience.